Drug Type Small molecule drug |
Synonyms CRB-556 |
Target |
Mechanism CB1 inverse agonists(Cannabinoid CB1 receptor inverse agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metabolic Diseases | Preclinical | US | - | |
Obesity | Preclinical | US | - |